A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab.
Baxter NN, Fischer HD, Richardson DP, Urbach DR, Bell CM, Rochon P, Brade A, Earle CC.
Baxter NN, et al.
Dis Colon Rectum. 2018 Mar;61(3):306-313. doi: 10.1097/DCR.0000000000000966.
Dis Colon Rectum. 2018.
PMID: 29420426
BACKGROUND: Patients receiving Bevacizumab, a vascular endothelial growth factor inhibitor used to treat metastatic colorectal cancer, may be at greater risk of complications after colorectal surgery because of impaired healing. OB …
BACKGROUND: Patients receiving Bevacizumab, a vascular endothelial growth factor inhibitor used to treat metastatic …